GNH USA

Europe — EMA

Onkotrone (Mitoxantrone Hydrochloride)

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is a antineoplastic agent presented as a sterile lyophilised powder for intravenous infusion use.

Request sourcing

1
Pack/s

What is Mitoxantrone Hydrochloride?

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is a antineoplastic agent presented as a sterile lyophilised powder for intravenous infusion use. It is employed in the treatment of certain hematologic malignancies and solid‑cell cancers for adults and adolesc who need intensive chemotherapy.

GNH USA supplies Onkotrone as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres and pharmacies worldwide.

What is Mitoxantrone Hydrochloride used for?

Onkotrone is an antineoplastic agent that works           …  …  ...  ...  …  ....  …  …  …  ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mitoxantrone Hydrochloride
Route
Intrapleural Use , Intravenous Use
Manufacturer
Baxter Healthcare Srl
Origin
EU

Related products